Far be it from a stoner to notice an industry trend, but I couldn’t help but observe that Critical Mass has been taking up an increasing amount of space in local dispensaries. Looking around various pot shop menus online confirmed the strain’s clout in the industry. But is Critical Mass also deserving of critical acclaim?
Search Results: strain/ (3)
I’ve always loved fruity-flavored cannabis. Not the citrus-heavy strains like Lemon Skunk or Grapefruit, which are great in their own way — but sweet and decadent strains like Cannalope Kush, Cherry Pie and Strawberry Cough. They’re a welcome break from OG-heavy kushes and pungent Diesels and Skunks. Everyone enjoys a visit to the candy shop sometimes, and when you get there, you’re going to want to pick up some Blueberry.
Blueberry is one of the few varieties of flower that you’ll find in a dispensary that might be older than you, other than landrace strains — and that’s because it was bred from them. Blueberry is part of an old genetics line developed by famed breeder DJ Short that includes other hits like Blue Moonshine and Flo. In the 1970s, Short introduced Blueberry to Europe after mixing together a pure Afghani indica with pure Thai and possibly Mexican sativas. The result was a heavy, indica-dominant hybrid with a smell and taste unknown to cannabis but familiar in kitchens: sweet, sweet blueberry pie. The strain’s rich flavor is much closer to frozen-juice concentrate than it is to diluted juice. Like Strawberry Cough, Blueberry has a syrupy aspect, but with earthy notes of hash at the end for balance rather than zest and spice.
A Boulder, Colorado medical marijuana dispensary recently tried honoring CNN’s Sanjay Gupta the best way they knew how: by naming a strain of kush after the well-known doctor who recently came out in favor of medical cannabis as a valid therapeutic treatment.
For their part, Gupta’s bosses at CNN aren’t very pleased. Helping Hands dispensary owner Jeff Kless says the media giant has asked him to stop selling the strain under that name. Kless tells Animal New York, however, that he’s not sure if that’s the route he’s going to take and was waiting for a cease and desist letter before he took any action.